Clinical Trial

Phosphate in Acute Pancreatitis

Study acronym: PPP
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn if phosphate administration works to treat acute pancreatitis in adults presenting to the emergency department at Duke University Hospital. The main questions it aims to answer are: * Does having low phosphate levels increase the risk of acute pancreatitis and can giving phosphate through an IV make the illness less severe? * Is phosphate therapy practical to use, and what is the appropriate dose? * Is this study achievable, and how can the results help design a future randomized controlled trial to assess safety and effectiveness? Participants will: * Receive standard of care or intravenous (IV) phosphate during their hospital stay * Have blood samples collected during admission to monitor phosphorus levels * Complete follow-up assessments after hospital admission to evaluate how severe the illness is and the effects of phosphate supplementation
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-19
minor Completion moved earlier: 2029-07 -> 2029-01 2026-07-09
Trial Details
NCT Number NCT07681050
Lead Sponsor Duke University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Pancreatitis
Enrollment 100 participants
Start Date 2026-07-09
Primary Completion 2028-07 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17